Sample Type,Primary Tumor Site,Primary Tumor Location,Age at Diagnosis,Stage at Diagnosis,Gender,Molecular Subtype,MSIsensor Score,mCRC Type,Chemo Exposure of sequenced specimen,Metastasectomy,Time to metastasis (months),Time from Met Dx to Sequencing,Tumor Grade,Liver: First Site of Metastasis,Lymph Nodes: First Site of Metastasis,Lung: First Site of Metastasis,Pelvis: First Site of Metastasis,Brain: First Site of Metastasis,Bone: First Site of Metastasis,"Peritoneum, omentum, abdomen: First Site of Metastasis",Gynecological: First Site of Metastasis,Other: First Site of Metastasis,Level R1,Level 2B,Level 3A,Level 3B,Highest Level of Actionability,Number of actionable alterations (OncoKb) ,BRAF classes for patients with BRAF mutations,Genomic Pathway Goups,Samples for MSS Right/Left mCRC anslysis,Samples for MSS Right/Left analysis,Samples for MSS Right/Left early stage analysis,Samples for MSS mCRC analysis,Hypermutated,Mutation Rate (mut/mb),Fraction of Genome Altered,Ratio of Indel to Substitutions,Average Sample Alele Frequency
Primary,Transverse Colon,Right,36,II,1,MSI,42.85,Early Stage Primary,0.0,0,0.0,0.0,poorly-diff,0,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12S)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,0,0,0,0,1,44.92753623,0.001231358,0.476190476,0.576897164
Metastasis,Ascending Colon,Right,60,II,0,MSI,29.81,mCRC Metastasis,0.0,0,38.16666667,2.766666667,Not_Provided,0,1,0,0,0,0,0,0,1,Not_Provided,Olaparib(BRCA2 p.T3033Lfs*29);Olaparib(BRCA2 p.E550del),Not_Provided,Not_Provided,LEVEL_2B,2,Not_Provided,none,0,0,0,0,1,27.53623188,0.003053029,0.52,0.398164427
Primary,Cecum,Right,58,IV,0,MSS,0.5,mCRC Primary,0.0,1,0.0,15.1,poorly-diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)","ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification)",LEVEL_2B,2,Not_Provided,RAS,1,1,0,1,0,5.833333333,0.097101104,0.0,0.447810114
Primary,Rectum,Left,65,I,0,MSS,0.36,mCRC Primary,0.0,0,5.7,13.33333333,mod_diff,1,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,5.833333333,0.154970835,0.166666667,0.396477359
Metastasis,Sigmoid Colon,Left,63,IV,1,MSS,0.1,mCRC Metastasis,0.0,1,0.0,10.1,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.5,0.40069022,0.0,0.475965126
Primary,Rectum,Left,57,IV,1,MSS,0.37,mCRC Primary,0.0,0,0.0,3.866666667,Not_Provided,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)","ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification)",LEVEL_2B,2,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.133288982,0.0,0.282011167
Primary,Sigmoid Colon,Left,49,III,1,MSS,0.26,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,0,1,1,0,0,3.333333333,0.056065226,0.333333333,0.416347095
Metastasis,Descending Colon,Left,63,IV,1,MSS,0.55,mCRC Metastasis,0.0,1,0.0,97.2,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.898550725,0.414284076,0.333333333,0.437301349
Primary,Rectum,Left,45,III,1,MSS,0.82,mCRC Primary,0.0,0,13.06666667,2.366666667,poorly-diff,0,1,0,0,0,1,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.160764749,0.2,0.515661934
Primary,Rectosigmoid,Left,49,III,0,MSS,1.11,mCRC Primary,0.0,1,0.0,-11.03333333,mod-poorly-diff,0,0,0,0,0,0,0,1,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.182743208,0.25,0.53453747
Metastasis,Transverse Colon,Left,69,II,1,MSS,1.7,mCRC Metastasis,0.0,1,9.933333333,7.733333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.430925101,0.4,0.601372802
Primary,Rectum,Left,46,II,0,MSI,16.51,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,0,0,0,0,0,6.666666667,0.238158666,0.0,0.510076768
Metastasis,Cecum,Right,69,III,0,MSS,3.68,mCRC Metastasis,0.0,0,40.0,1.433333333,mod_diff,1,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.52173913,0.621675671,0.0,0.507287284
Metastasis,Descending Colon,Left,59,IV,1,MSS,0.24,mCRC Metastasis,0.0,1,0.0,28.26666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.173913043,0.094111863,0.0,0.4948789
Primary,Rectosigmoid,Left,43,III,0,MSI,33.36,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Olaparib(BRCA2 p.N1784Tfs*7);Everolimus(TSC1 p.D476Ifs*56),Not_Provided,"Neratinib(ERBB2 p.V842I);Sonidegib,Vismodegib(PTCH1 p.R1308Efs*64)",LEVEL_2B,4,Not_Provided,PI3k_RAS,0,0,0,0,1,46.37681159,0.005260285,0.361702128,0.554045591
Primary,Sigmoid Colon,Left,41,IV,0,MSS,0.54,mCRC Primary,0.0,1,0.0,113.0,mod_diff,1,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,1.449275362,0.02149265,1.0,0.35823174
Metastasis,Descending Colon,Left,52,IV,1,MSS,0.19,mCRC Metastasis,0.0,1,0.0,41.43333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification)",LEVEL_2B,2,Not_Provided,RTK_ONLY,1,1,0,1,0,2.173913043,0.046818463,0.5,0.418173523
Metastasis,Sigmoid Colon,Left,50,I,1,MSS,1.67,mCRC Metastasis,0.0,0,29.5,17.76666667,Not_Provided,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.833333333,0.225450818,0.166666667,0.586303929
Primary,Rectum,Left,44,III,0,MSS,0.42,mCRC Primary,0.0,1,37.7,11.26666667,poorly-diff,0,1,1,1,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.Q61R)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.971014493,0.129892299,0.1,0.50456433
Primary,Hepatic Flexure,Right,63,IV,0,MSS,0.33,mCRC Primary,0.0,0,0.0,5.166666667,Not_Provided,0,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.070157425,0.111111111,0.520031211
Metastasis,Ascending Colon,Right,43,III,0,MSS,0.98,mCRC Metastasis,0.0,1,13.53333333,14.8,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RTK_ONLY,1,1,0,1,0,4.347826087,0.352215828,0.0,0.419210993
Metastasis,Sigmoid Colon,Left,67,IV,1,MSS,0.0,mCRC Metastasis,0.0,1,0.0,15.26666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.623188406,0.071598996,0.666666667,0.373096514
Primary,Sigmoid Colon,Left,57,III,1,MSS,1.3,mCRC Primary,0.0,0,36.33333333,1.8,mod_diff,0,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.623188406,0.32186326,0.25,0.649253372
Metastasis,Cecum,Right,57,IV,0,MSI,41.71,mCRC Metastasis,0.0,0,0.0,19.26666667,mod-poorly-diff,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12A)","Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,"alpelisib(PIK3CA p.H1047R);Sonidegib,Vismodegib(PTCH1 p.R1308Qfs*17)",LEVEL_2B,3,1,PI3k_RAS,0,0,0,0,1,46.66666667,0.096852979,0.390243902,0.351080688
Primary,Cecum,Right,72,II,1,MSS,0.08,mCRC Primary,0.0,0,21.43333333,5.333333333,poorly-diff,0,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,No_class,PI3k_RAS,1,1,0,1,0,5.797101449,0.005472997,0.333333333,0.389058739
Primary,Ascending Colon,Right,47,IV,0,MSS,0.72,mCRC Primary,0.0,0,0.0,12.3,mod_diff,0,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3K,1,1,0,1,0,5.072463768,0.295386147,1.333333333,0.398193291
Primary,Sigmoid Colon,Left,63,III,1,MSS,0.55,mCRC Primary,0.0,0,12.23333333,9.2,poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,6.666666667,0.168992553,0.142857143,0.561236971
Primary,Sigmoid Colon,Left,31,III,1,MSS,1.64,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12A)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,1,1,0,0,3.623188406,0.408545016,0.25,0.479826187
Primary,Cecum,Right,46,I,1,MSS,0.31,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,1,1,0,0,5.797101449,0.042404157,0.6,0.468068729
Metastasis,Rectum,Left,61,IV,1,MSS,3.0,mCRC Metastasis,0.0,0,0.0,7.6,Not_Provided,1,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,0,0,0,0,2.898550725,0.217919769,0.0,0.481178574
Primary,Ascending Colon,Right,65,III,0,MSI,36.42,Early Stage Primary,0.0,0,0.0,0.0,poorly-diff,0,0,0,0,0,0,0,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E);Olaparib(BRCA2 p.I605Yfs*9);Everolimus(TSC1 p.L113Cfs*5)",Not_Provided,Not_Provided,LEVEL_2B,3,1,PI3k_RAS,0,0,0,0,1,53.62318841,0.040129719,0.450980392,0.406420861
Metastasis,Colon,Not_Provided,68,IV,1,MSS,1.19,mCRC Metastasis,0.0,1,0.0,163.6333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,0,0,0,1,0,3.623188406,0.336720913,0.0,0.645875428
Metastasis,Rectum,Left,57,IV,1,MSS,0.14,mCRC Metastasis,0.0,0,0.0,33.46666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.623188406,0.099000348,0.25,0.355955079
Primary,Rectum,Left,69,I,1,MSS,1.36,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,Olaparib(BRCA1 p.N567Pfs*16),Not_Provided,Not_Provided,LEVEL_2B,1,Not_Provided,RTK_ONLY,0,1,1,0,0,4.347826087,0.333226767,0.5,0.440061547
Primary,Cecum,Right,34,IV,1,MSS,0.38,Early Stage Primary,0.0,1,0.0,12.0,mod-poorly-diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,3,PI3k_RAS,0,1,1,0,0,13.76811594,0.183641842,0.055555556,0.362375313
Primary,Sigmoid Colon,Left,46,IV,0,MSS,0.89,mCRC Primary,0.0,0,0.0,20.03333333,poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.898550725,0.15727378,0.333333333,0.471118477
Primary,Sigmoid Colon,Left,27,IV,1,MSS,0.18,mCRC Primary,0.0,0,0.0,33.96666667,mod_diff,1,1,0,0,0,0,0,0,0,Not_Provided,"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification)",LEVEL_2B,2,Not_Provided,RTK_ONLY,1,1,0,1,0,2.5,1.23e-05,0.5,0.343335702
Metastasis,Transverse Colon,Right,45,IV,0,MSS,0.22,mCRC Metastasis,0.0,0,0.0,18.5,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.037758269,0.2,0.33194281
Metastasis,Rectosigmoid,Left,57,IV,1,MSS,0.0,mCRC Metastasis,0.0,1,0.0,43.3,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,8.695652174,0.058215413,0.090909091,0.461024996
Primary,Rectum,Left,62,III,1,MSS,0.42,mCRC Primary,0.0,0,4.5,1.533333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.224247273,0.142857143,0.453338269
Metastasis,Cecum,Right,59,III,0,MSS,0.57,mCRC Metastasis,0.0,0,19.46666667,20.16666667,mod_diff,0,0,0,1,0,0,1,1,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,Not_Provided,LEVEL_2B,1,1,RAS,1,1,0,1,0,10.14492754,0.281454918,0.166666667,0.69915949
Primary,Sigmoid Colon,Left,69,II,0,MSS,0.6,mCRC Primary,0.0,0,4.6,10.06666667,mod_diff,0,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.166666667,0.22646194,0.666666667,0.483942235
Metastasis,Transverse Colon,Right,37,IV,1,MSS,0.64,mCRC Metastasis,0.0,0,0.0,4.666666667,Not_Provided,1,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.A146T)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.R88Q),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.797101449,0.283458206,0.333333333,0.561573384
Metastasis,Not_Provided,Not_Provided,81,III,1,MSS,1.63,mCRC Metastasis,0.0,0,25.33333333,16.13333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,0,0,1,0,6.52173913,0.411083611,0.125,0.414078879
Primary,Rectum,Left,47,III,0,MSS,0.0,mCRC Primary,0.0,0,30.0,1.866666667,mod_diff,0,0,1,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,1.449275362,0.088625877,1.0,0.344608394
Metastasis,Rectum,Left,49,IV,0,MSS,1.61,mCRC Metastasis,0.0,1,0.0,31.6,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.623188406,0.520782668,0.25,0.476420939
Metastasis,Sigmoid Colon,Left,49,IV,0,MSS,0.09,mCRC Metastasis,0.0,1,0.0,5.266666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,3.623188406,0.214020768,0.25,0.421580129
Primary,Ascending Colon,Right,33,III,1,MSI,38.44,mCRC Primary,0.0,1,16.6,32.96666667,Not_Provided,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.Q61H)",Olaparib(BRCA2 p.I605Yfs*9);Olaparib(BRCA1 p.L1764*),Not_Provided,Not_Provided,LEVEL_2B,2,Not_Provided,PI3k_RAS,0,0,0,0,1,48.55072464,0.007454543,0.288461538,0.497325802
Primary,Rectum,Left,71,IV,0,MSS,0.15,mCRC Primary,0.0,0,0.0,3.466666667,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.K117N)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.173913043,0.010175606,0.0,0.33965474
Primary,Rectum,Left,68,II,1,MSS,0.0,mCRC Primary,0.0,0,32.66666667,5.233333333,mod_diff,1,1,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.0,0.211537535,0.2,0.77793005
Metastasis,Sigmoid Colon,Left,68,IV,1,MSS,0.16,mCRC Metastasis,0.0,1,0.0,39.73333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.156623756,0.2,0.45888639
Metastasis,Sigmoid Colon,Left,72,IV,1,MSS,0.0,mCRC Metastasis,0.0,1,0.0,3.833333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12A)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.080998398,0.2,0.572875026
Primary,Left Colon,Left,66,IV,0,MSS,0.88,mCRC Primary,0.0,1,0.0,73.66666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.347826087,0.327112021,0.2,0.432752658
Primary,Hepatic Flexure,Right,74,II,1,MSI,29.17,mCRC Primary,0.0,0,3.633333333,7.4,Not_Provided,0,0,0,0,0,0,1,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,alpelisib(PIK3CA p.Q546K),LEVEL_2B,2,1,PI3k_RAS,0,0,0,0,1,31.66666667,0.026743929,0.461538462,0.497490577
Primary,Ascending Colon,Right,56,IV,0,MSS,0.08,mCRC Primary,0.0,0,0.0,1.666666667,Not_Provided,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V);Cetuximab,Panitumumab(KRAS p.G12A)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.797101449,0.051298559,0.142857143,0.396570759
Primary,Cecum,Right,56,IV,0,MSS,0.0,mCRC Primary,0.0,0,0.0,5.666666667,poorly-diff,1,0,0,0,0,0,1,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,Not_Provided,LEVEL_2B,1,1,RAS,1,1,0,1,0,4.347826087,0.02478026,0.0,0.421229671
Metastasis,Rectum,Left,39,IV,1,MSS,0.15,mCRC Metastasis,0.0,0,0.0,1.966666667,Not_Provided,1,0,1,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.210980383,0.5,0.400626791
Primary,Rectum,Left,49,IV,1,MSS,0.53,mCRC Primary,0.0,1,0.0,4.9,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.347826087,0.302686406,0.2,0.372013448
Primary,Ascending Colon,Right,75,III,0,MSS,1.48,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,1,1,0,0,7.246376812,0.384267143,0.428571429,0.576565723
Primary,Sigmoid Colon,Left,48,III,1,MSS,0.83,mCRC Primary,0.0,0,0.0,-14.96666667,Not_Provided,0,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(NRAS p.Q61R)",Not_Provided,Not_Provided,"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61R)",LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,4.347826087,0.363771296,0.2,0.436461319
Metastasis,Sigmoid Colon,Left,56,IV,1,MSS,0.0,mCRC Metastasis,0.0,0,0.0,29.06666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,2,RAS,1,1,0,1,0,4.347826087,1.18e-05,2.0,0.455830878
Primary,Rectosigmoid,Left,61,IV,1,MSS,3.13,mCRC Primary,0.0,1,0.0,63.03333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,1.666666667,0.189711277,1.0,0.843286762
Primary,Sigmoid Colon,Left,52,IV,0,MSS,0.08,mCRC Primary,0.0,1,0.0,6.6,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12A)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.31207165,0.5,0.516717408
Metastasis,Rectum,Left,66,III,1,MSS,0.41,mCRC Metastasis,0.0,1,27.8,1.033333333,poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification)",LEVEL_2B,2,Not_Provided,RTK_ONLY,1,1,0,1,0,5.072463768,0.201200049,0.4,0.418464038
Primary,Rectum,Left,40,IV,0,MSS,0.75,mCRC Primary,0.0,1,0.0,6.0,mod-poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.623188406,0.135460956,0.0,0.487493787
Primary,Sigmoid Colon,Left,60,III,0,MSS,0.65,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.R93W),LEVEL_3B,1,Not_Provided,PI3k_RAS,0,1,1,0,0,3.623188406,0.22161317,0.666666667,0.381026376
Metastasis,Sigmoid Colon,Left,45,III,1,POLE,0.31,mCRC Metastasis,0.0,1,8.6,26.5,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.V14I)",Olaparib(BRCA2 p.S1442*),Not_Provided,alpelisib(PIK3CA p.E365K),LEVEL_2B,2,No_class,PI3k_RAS,0,0,0,0,1,207.5,7.5e-06,0.004032258,0.54817833
Primary,Transverse Colon,Right,31,IV,1,MSS,0.0,mCRC Primary,0.0,0,0.0,4.833333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.A146V)","ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification);Neratinib(ERBB2 p.V777L)",LEVEL_2B,3,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.003420725,0.166666667,0.348618347
Primary,Sigmoid Colon,Left,53,IV,1,MSS,0.0,mCRC Primary,0.0,0,0.0,20.66666667,mod-poorly-diff,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.173913043,0.000578738,0.5,0.377337061
Metastasis,Splenic Flexure,Left,55,IV,0,MSS,2.9,mCRC Metastasis,0.0,1,0.0,155.8333333,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RTK_ONLY,1,1,0,1,0,2.5,0.420741832,0.0,0.394531113
Primary,Rectum,Left,57,IV,1,MSS,0.12,mCRC Primary,0.0,0,0.0,7.166666667,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.5,0.044099802,0.5,0.305966382
Metastasis,Rectosigmoid,Left,55,IV,1,MSS,1.15,mCRC Metastasis,0.0,0,0.0,2.233333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12A)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.971014493,0.199240719,0.222222222,0.824139639
Primary,Rectum,Left,53,II,0,MSS,0.0,mCRC Primary,0.0,0,7.5,4.133333333,Not_Provided,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,3.623188406,0.014340592,0.0,0.447825231
Metastasis,Splenic Flexure,Left,69,IV,0,MSS,1.91,mCRC Metastasis,0.0,0,0.0,13.23333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12S)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.072463768,0.344135131,0.0,0.354797597
Metastasis,Descending Colon,Left,72,IV,1,MSS,0.42,mCRC Metastasis,0.0,1,0.0,55.0,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12A)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.52173913,0.14651449,0.285714286,0.406721862
Primary,Rectosigmoid,Left,47,I,0,MSI,17.95,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Olaparib(BRCA2 p.N986Ifs*5),Not_Provided,alpelisib(PIK3CA p.E545K),LEVEL_2B,2,Not_Provided,PI3k_RAS,0,0,0,0,1,52.89855072,0.001928037,0.089552239,0.366336555
Primary,Rectum,Left,61,II,1,MSS,0.34,mCRC Primary,0.0,0,0.0,-19.63333333,mod_diff,0,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.163001859,0.333333333,0.453204782
Metastasis,Sigmoid Colon,Left,55,IV,1,MSS,0.15,mCRC Metastasis,0.0,0,0.0,19.83333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,5.072463768,0.174818497,0.4,0.372044018
Metastasis,Splenic Flexure,Left,43,IV,0,MSS,1.13,mCRC Metastasis,0.0,1,0.0,61.36666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,"AZD4547,Dovitinib(FGFR1 Amplification)",LEVEL_3B,1,Not_Provided,PI3K,1,1,0,1,0,5.072463768,0.379041096,0.0,0.552035354
Metastasis,Sigmoid Colon,Left,45,III,1,MSS,0.06,mCRC Metastasis,0.0,0,51.2,1.1,mod_diff,0,1,1,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.898550725,0.121363425,1.0,0.411731276
Primary,Descending Colon,Left,41,II,1,MSI,29.5,Early Stage Primary,0.0,0,0.0,0.0,Not_Provided,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,"Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52)",LEVEL_3B,1,Not_Provided,PI3K,0,0,0,0,1,47.5,0.049142215,0.266666667,0.375757784
Metastasis,Transverse Colon,Right,64,IV,0,MSS,0.43,mCRC Metastasis,0.0,0,0.0,1.633333333,Not_Provided,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.Q61H)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.898550725,0.198853277,0.0,0.30186737
Metastasis,Rectosigmoid,Left,70,IV,1,MSS,1.38,mCRC Metastasis,0.0,0,0.0,2.966666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,6.52173913,0.231741305,0.285714286,0.541889199
Primary,Sigmoid Colon,Left,68,IV,0,MSS,0.07,mCRC Primary,0.0,0,0.0,3.1,Not_Provided,1,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,4.347826087,0.110269344,0.0,0.343670641
Metastasis,Transverse Colon,Right,55,IV,1,MSI,3.16,mCRC Metastasis,0.0,0,0.0,62.13333333,mod_diff,0,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,"Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.Q56P)",LEVEL_3B,1,Not_Provided,RAS,0,0,0,0,1,47.82608696,0.004788601,0.32,0.41539993
Primary,Ascending Colon,Right,51,II,1,MSS,0.17,mCRC Primary,0.0,1,14.83333333,28.83333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12A);Cetuximab,Panitumumab(NRAS p.Q61K)",Not_Provided,Not_Provided,"AZD5363(AKT1 p.E17K);Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61K)",LEVEL_3B,2,Not_Provided,PI3k_RAS,1,1,0,1,0,6.52173913,0.181951983,0.125,0.4365855
Primary,Rectosigmoid,Left,57,IV,0,MSS,1.08,mCRC Primary,0.0,0,0.0,1.3,Not_Provided,0,1,1,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.898550725,0.1117315,0.333333333,0.461412973
Metastasis,Rectum,Left,56,IV,1,MSS,0.0,mCRC Metastasis,0.0,0,0.0,24.43333333,Not_Provided,1,1,1,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,"Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.K57T);alpelisib(PIK3CA p.*1069F)",LEVEL_3B,2,Not_Provided,none,1,1,0,1,0,5.797101449,0.151035282,0.142857143,0.294996608
Metastasis,Rectum,Left,50,II,0,MSS,0.55,mCRC Metastasis,0.0,1,12.06666667,2.133333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.898550725,0.293006122,0.0,0.381688957
Metastasis,Sigmoid Colon,Left,33,IV,0,MSS,0.09,mCRC Metastasis,0.0,0,0.0,1.466666667,Not_Provided,0,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.347826087,0.035161,0.0,0.407690625
Primary,Transverse Colon,Right,42,IV,0,MSS,0.0,mCRC Primary,0.0,1,0.0,25.33333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,alpelisib(PIK3CA p.E542K),LEVEL_3B,1,Not_Provided,PI3K,1,1,0,1,0,4.166666667,0.002709948,0.25,0.396450131
Primary,Rectum,Left,61,III,1,MSS,0.07,mCRC Primary,0.0,0,0.0,-4.166666667,poorly-diff,0,0,0,1,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,5.797101449,0.015633556,0.142857143,0.465992134
Primary,Transverse Colon,Left,69,IV,0,MSS,0.77,mCRC Primary,0.0,0,0.0,19.86666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,alpelisib(PIK3CA p.R88Q),LEVEL_3B,1,Not_Provided,PI3K,1,1,0,1,0,7.971014493,0.214031344,0.1,0.682929017
Primary,Ascending Colon,Right,73,IV,0,MSS,1.35,mCRC Primary,0.0,1,0.0,4.9,mod-poorly-diff,0,0,0,0,0,0,1,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,Not_Provided,LEVEL_2B,1,1,RAS,1,1,0,1,0,4.347826087,0.627414736,0.2,0.495804295
Metastasis,Hepatic Flexure,Right,78,III,1,MSS,0.15,mCRC Metastasis,0.0,0,25.8,3.566666667,mod_diff,0,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.173913043,0.031883598,0.5,0.360499571
Primary,Sigmoid Colon,Left,34,III,1,MSS,0.0,mCRC Primary,0.0,0,1.333333333,3.0,mod-poorly-diff,1,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,"Cobimetinib,Trametinib,Selumetinib(MAP2K1 p.K57N)",LEVEL_3B,1,Not_Provided,none,1,1,0,1,0,6.52173913,0.124899236,0.5,0.45704211
Primary,Descending Colon,Left,68,III,0,MSI,27.12,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,alpelisib(PIK3CA p.R93Q),LEVEL_3B,1,Not_Provided,PI3K,0,0,0,0,1,47.82608696,0.000577881,0.434782609,0.402760735
Metastasis,Rectum,Left,55,II,0,MSS,0.86,mCRC Metastasis,0.0,1,16.4,69.9,Not_Provided,0,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,5.797101449,0.085494039,1.0,0.434082836
Primary,Rectum,Left,67,IV,0,MSS,1.15,mCRC Primary,0.0,1,0.0,13.66666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,5.797101449,0.265674524,0.333333333,0.385934522
Primary,Cecum,Right,43,IV,0,MSS,1.55,mCRC Primary,0.0,0,0.0,10.43333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.M1043L),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.797101449,0.375573934,0.142857143,0.462446271
Primary,Sigmoid Colon,Left,37,III,1,MSS,0.15,mCRC Primary,0.0,0,10.43333333,4.366666667,poorly-diff,0,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,5.0,0.044453248,0.5,0.307342259
Metastasis,Hepatic Flexure,Right,54,III,1,MSS,3.77,mCRC Metastasis,0.0,0,33.76666667,2.833333333,poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,2.173913043,0.77919033,0.0,0.465106482
Metastasis,Ascending Colon,Right,80,IV,1,MSS,0.0,mCRC Metastasis,0.0,0,0.0,2.666666667,Not_Provided,0,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,10.14492754,0.11363508,0.166666667,0.540766661
Metastasis,Rectum,Left,34,III,0,MSS,0.22,mCRC Metastasis,0.0,1,6.866666667,26.9,Not_Provided,0,0,1,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,5.072463768,0.170603185,0.0,0.506191874
Primary,Rectum,Left,35,IV,1,MSS,0.18,mCRC Primary,0.0,0,0.0,18.2,Not_Provided,0,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.5,0.027984569,0.5,0.406762003
Metastasis,Sigmoid Colon,Left,42,IV,1,MSS,0.27,mCRC Metastasis,0.0,1,0.0,28.26666667,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,5.072463768,0.060685571,0.0,0.327682183
Primary,Cecum,Right,26,III,1,MSS,0.0,mCRC Primary,0.0,0,9.333333333,5.633333333,Not_Provided,0,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.173913043,1.81e-05,0.0,0.362285135
Metastasis,Ascending Colon,Right,67,III,1,MSS,0.3,mCRC Metastasis,0.0,1,12.16666667,1.9,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.A146T)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.119981376,0.25,0.479923448
Primary,Sigmoid Colon,Left,54,I,1,MSS,0.0,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,0,1,1,0,0,3.333333333,0.045975755,0.0,0.281157103
Metastasis,Sigmoid Colon,Left,44,IV,1,MSS,0.26,mCRC Metastasis,0.0,0,0.0,8.833333333,Not_Provided,1,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.173913043,0.210819524,2.0,0.599432172
Primary,Cecum,Right,47,IV,1,MSS,0.07,mCRC Primary,0.0,0,0.0,30.0,mod_diff,0,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.H1047L),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,18.84057971,0.03541723,0.130434783,0.453301722
Metastasis,Ascending Colon,Right,58,I,0,MSS,2.4,mCRC Metastasis,0.0,0,35.93333333,25.96666667,mod_diff,0,1,0,0,0,0,0,0,0,Not_Provided,"Crizotinib(MET Amplification);Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,Not_Provided,LEVEL_2B,2,1,RAS,1,1,0,1,0,5.833333333,0.698169792,0.4,0.438997539
Primary,Transverse Colon,Right,22,II,0,MSI,14.48,mCRC Primary,0.0,1,10.83333333,15.6,Not_Provided,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,"alpelisib(PIK3CA p.H1047R);Sonidegib,Vismodegib(PTCH1 p.S1203Afs*52)",LEVEL_3B,2,Not_Provided,PI3k_RAS,0,0,0,0,0,19.16666667,0.000157438,0.277777778,0.503764739
Primary,Descending Colon,Left,53,IV,0,MSS,0.89,mCRC Primary,0.0,1,0.0,5.8,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.166666667,0.179233059,0.0,0.846135637
Metastasis,Rectum,Left,72,I,0,MSS,0.18,mCRC Metastasis,0.0,0,24.43333333,26.23333333,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.347826087,0.181781608,1.0,0.260630337
Primary,Rectum,Left,64,II,1,MSS,0.97,mCRC Primary,0.0,0,29.53333333,2.2,poorly-diff,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(NRAS p.Q61K)",Not_Provided,Not_Provided,"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61K)",LEVEL_3B,1,Not_Provided,RAS,1,1,0,1,0,2.898550725,0.205385538,0.0,0.512249192
Primary,Ascending Colon,Right,75,IV,0,MSS,1.19,mCRC Primary,0.0,1,0.0,31.23333333,Not_Provided,1,1,0,1,0,0,0,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,Not_Provided,LEVEL_2B,1,Not_Provided,RAS,0,0,0,0,0,12.5,0.276703288,0.071428571,0.326784374
Primary,Transverse Colon,Right,69,IV,1,MSS,0.26,mCRC Primary,0.0,0,0.0,1.966666667,mod_diff,0,1,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.623188406,0.098500403,0.25,0.39303174
Metastasis,Rectosigmoid,Left,53,IV,1,MSS,1.38,mCRC Metastasis,0.0,1,0.0,91.43333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification)",LEVEL_2B,2,Not_Provided,RTK_ONLY,1,1,0,1,0,5.0,0.408548442,0.0,0.640434675
Metastasis,Ascending Colon,Right,46,IV,0,MSS,0.28,mCRC Metastasis,0.0,1,0.0,63.1,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,4.84e-06,0.166666667,0.509619434
Metastasis,Descending Colon,Left,44,IV,1,MSS,0.83,mCRC Metastasis,0.0,1,0.0,41.23333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RTK_ONLY,1,1,0,1,0,2.173913043,0.408588091,0.5,0.51956316
Primary,Rectum,Left,57,IV,1,MSS,0.35,mCRC Primary,0.0,0,0.0,37.9,mod_diff,1,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,6.666666667,0.250317992,0.142857143,0.517698667
Metastasis,Rectum,Left,61,IV,0,MSS,2.2,mCRC Metastasis,0.0,0,0.0,1.566666667,Not_Provided,1,1,0,0,0,1,0,0,0,Not_Provided,Not_Provided,Not_Provided,"AZD4547,Dovitinib(FGFR1 Amplification)",LEVEL_3B,1,Not_Provided,RTK_ONLY,1,1,0,1,0,2.173913043,0.401879048,0.5,0.63694271
Primary,Sigmoid Colon,Left,68,IV,1,MSS,1.03,mCRC Primary,0.0,0,0.0,2.5,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,"AZD4547,Dovitinib(FGFR1 Amplification)",LEVEL_3B,1,Not_Provided,none,1,1,0,1,0,2.898550725,0.323586054,0.333333333,0.470157033
Metastasis,Sigmoid Colon,Left,61,IV,0,MSS,3.87,mCRC Metastasis,0.0,0,0.0,1.633333333,Not_Provided,1,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,7.246376812,0.817722709,0.25,0.551263019
Primary,Cecum,Right,65,IV,0,MSS,0.09,mCRC Primary,0.0,1,0.0,16.93333333,mod_diff,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,4.347826087,0.142121151,0.5,0.468777288
Metastasis,Sigmoid Colon,Left,69,IV,1,MSS,1.02,mCRC Metastasis,0.0,1,0.0,65.63333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.5,0.244687838,0.0,0.453393736
Primary,Cecum,Right,61,IV,0,MSS,0.33,mCRC Primary,0.0,0,0.0,7.766666667,mod_diff,0,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.128876331,0.25,0.365084677
Primary,Hepatic Flexure,Right,45,IV,1,MSS,0.89,mCRC Primary,0.0,0,0.0,28.3,poorly-diff,1,1,0,0,0,0,1,0,0,Not_Provided,Crizotinib(MET Amplification),Not_Provided,Not_Provided,LEVEL_2B,1,Not_Provided,RTK_ONLY,1,1,0,1,0,5.072463768,0.562485312,0.4,0.550346324
Primary,Transverse Colon,Right,81,I,0,MSI,30.74,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,alpelisib(PIK3CA p.H1047R),LEVEL_2B,2,1,PI3k_RAS,0,0,0,0,1,24.63768116,0.13507925,0.416666667,0.380979393
Metastasis,Not_Provided,Not_Provided,35,IV,1,MSS,0.08,mCRC Metastasis,0.0,1,0.0,69.26666667,Not_Provided,0,0,0,0,0,0,0,0,1,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,3,RAS,0,0,0,1,0,2.173913043,0.014056415,0.0,0.272146679
Metastasis,Sigmoid Colon,Left,52,I,1,MSS,1.16,mCRC Metastasis,0.0,0,118.1666667,22.53333333,Not_Provided,1,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.5,0.277920181,0.0,0.566591682
Metastasis,Descending Colon,Left,65,IV,1,MSS,2.73,mCRC Metastasis,0.0,1,0.0,8.3,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.52173913,0.332631943,0.285714286,0.751324706
Metastasis,Cecum,Right,47,IV,1,MSS,0.56,mCRC Metastasis,0.0,1,0.0,34.2,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.52173913,0.077723259,0.5,0.353170032
Metastasis,Sigmoid Colon,Left,61,II,0,MSS,1.63,mCRC Metastasis,0.0,0,13.06666667,4.133333333,Not_Provided,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.52173913,0.302355196,0.125,0.453434908
Metastasis,Cecum,Right,58,II,1,MSS,0.08,mCRC Metastasis,0.0,1,21.4,26.1,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.097040014,0.0,0.431797141
Metastasis,Transverse Colon,Right,28,IV,1,MSS,1.11,mCRC Metastasis,0.0,1,0.0,3.9,mod-poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,Not_Provided,LEVEL_2B,1,1,RAS,1,1,0,1,0,5.797101449,0.346419676,0.0,0.501345094
Metastasis,Sigmoid Colon,Left,68,IV,0,MSS,0.76,mCRC Metastasis,0.0,1,0.0,2.133333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,5.797101449,0.247167184,0.142857143,0.409532659
Primary,Sigmoid Colon,Left,62,IV,1,MSS,0.57,mCRC Primary,0.0,0,0.0,4.566666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RTK_ONLY,1,1,0,1,0,5.0,0.287268807,0.0,0.497713168
Primary,Rectosigmoid,Left,50,III,0,MSS,1.04,mCRC Primary,0.0,1,25.53333333,11.6,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.898550725,0.583503269,0.0,0.582454538
Metastasis,Sigmoid Colon,Left,46,III,1,MSS,0.34,mCRC Metastasis,0.0,1,13.1,52.03333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,0,0,0,0,0,4.347826087,0.058296868,0.0,0.522425175
Metastasis,Sigmoid Colon,Left,37,IV,1,MSS,0.18,mCRC Metastasis,0.0,1,0.0,40.33333333,mod_diff,1,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.623188406,0.069375505,0.0,0.537425812
Metastasis,Rectum,Left,42,II,1,MSS,1.15,mCRC Metastasis,0.0,1,16.26666667,28.36666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.898550725,0.287260526,0.333333333,0.61150673
Metastasis,Rectum,Left,40,III,1,MSS,0.49,mCRC Metastasis,0.0,1,3.8,28.6,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(NRAS p.Q61K)",Not_Provided,Not_Provided,"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61K)",LEVEL_3B,1,Not_Provided,RAS,1,1,0,1,0,3.333333333,0.236157084,0.0,0.404584971
Primary,Transverse Colon,Right,63,IV,0,MSS,0.7,mCRC Primary,0.0,0,0.0,3.433333333,Not_Provided,1,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,3.623188406,0.27614605,0.25,0.521366937
Metastasis,Cecum,Right,48,III,1,MSS,0.17,mCRC Metastasis,0.0,1,58.06666667,26.13333333,poorly-diff,0,0,0,1,0,0,0,0,1,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.347826087,0.11522704,0.0,0.491263873
Primary,Rectum,Left,67,II,0,MSS,0.17,Early Stage Primary,0.0,0,32.83333333,0.0,mod_diff,0,0,1,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Neratinib(ERBB2 p.S310F),LEVEL_3B,1,Not_Provided,RTK_ONLY,0,1,1,0,0,1.449275362,5.98e-07,0.0,0.405200699
Primary,Sigmoid Colon,Left,66,IV,0,MSS,0.32,mCRC Primary,0.0,1,0.0,3.033333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.347826087,0.223918279,0.2,0.425408153
Primary,Rectum,Left,29,III,1,MSI,35.18,mCRC Primary,0.0,1,11.36666667,4.7,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3K,0,0,0,0,1,47.10144928,0.019891915,0.585365854,0.415287378
Primary,Rectosigmoid,Left,38,IV,1,MSS,0.0,mCRC Primary,0.0,0,0.0,21.83333333,Not_Provided,1,0,1,0,0,1,1,0,0,Not_Provided,"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification);Neratinib(ERBB2 p.V777L)",LEVEL_2B,3,Not_Provided,RTK_ONLY,1,1,0,1,0,2.173913043,0.081776609,0.0,0.43265166
Metastasis,Rectum,Left,55,III,0,MSS,0.11,mCRC Metastasis,0.0,0,31.9,53.73333333,Not_Provided,0,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12A)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.342989641,0.333333333,0.685570981
Primary,Descending Colon,Left,81,II,0,MSI,27.79,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,0,0,0,1,25.36231884,0.001802055,0.458333333,0.492552723
Metastasis,Hepatic Flexure,Right,62,IV,0,MSS,0.18,mCRC Metastasis,0.0,1,0.0,66.2,mod_diff,1,0,0,0,0,0,0,1,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,7.5,0.214113351,0.125,0.465994779
Metastasis,Sigmoid Colon,Left,53,IV,1,MSS,0.09,mCRC Metastasis,0.0,1,0.0,36.93333333,mod_diff,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.5,0.194354571,0.5,0.438494986
Primary,Sigmoid Colon,Left,47,IV,0,MSS,0.6,mCRC Primary,0.0,1,0.0,3.0,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.358796524,0.0,0.397273724
Primary,Rectum,Left,65,IV,1,MSS,0.08,mCRC Primary,0.0,0,0.0,16.2,Not_Provided,1,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.833333333,0.000357928,0.333333333,0.326223587
Metastasis,Rectosigmoid,Left,48,IV,0,MSS,2.14,mCRC Metastasis,0.0,1,0.0,116.0333333,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.623188406,0.371446164,0.25,0.582598076
Primary,Cecum,Right,78,IV,1,MSS,0.07,mCRC Primary,0.0,1,0.0,19.6,mod_diff,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,7.246376812,0.111806359,0.25,0.383501312
Metastasis,Cecum,Right,70,III,1,MSS,0.83,mCRC Metastasis,0.0,1,15.23333333,14.33333333,mod_diff,0,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.216377616,0.5,0.456243472
Metastasis,Rectum,Left,64,II,1,MSS,0.58,mCRC Metastasis,0.0,1,17.76666667,8.033333333,mod_diff,0,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.098030267,0.25,0.586795782
Metastasis,Sigmoid Colon,Left,45,IV,1,MSS,0.15,mCRC Metastasis,0.0,0,0.0,9.433333333,Not_Provided,0,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,0.724637681,0.020457271,0.0,0.418236154
Primary,Cecum,Right,79,III,1,MSI,28.39,Early Stage Primary,0.0,0,0.0,0.0,mod-poorly-diff,0,0,0,0,0,0,0,0,0,Not_Provided,Olaparib(BRCA2 p.E2981Rfs*37),Not_Provided,alpelisib(PIK3CA p.E81K),LEVEL_2B,2,No_class,PI3k_RAS,0,0,0,0,1,34.05797101,4.16e-07,0.46875,0.346873176
Metastasis,Rectosigmoid,Left,70,III,0,MSS,0.0,mCRC Metastasis,0.0,1,0.0,4.066666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.347826087,0.00138664,0.2,0.326309326
Primary,Rectosigmoid,Left,54,IV,1,MSS,1.47,mCRC Primary,0.0,0,0.0,4.8,poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.173913043,0.224899628,0.0,0.342264054
Metastasis,Ascending Colon,Right,70,III,1,MSS,0.38,mCRC Metastasis,0.0,1,19.7,7.233333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification)",LEVEL_2B,2,Not_Provided,RTK_ONLY,1,1,0,1,0,2.898550725,0.109639368,0.0,0.463522127
Primary,Sigmoid Colon,Left,56,IV,1,MSS,0.68,mCRC Primary,0.0,0,0.0,12.2,mod_diff,0,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.A146T)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.E545K);alpelisib(PIK3CA p.H1047R),LEVEL_3B,2,Not_Provided,PI3k_RAS,1,1,0,1,0,5.072463768,0.081786403,0.4,0.550498552
Metastasis,Cecum,Right,52,II,0,MSS,1.39,mCRC Metastasis,0.0,0,14.73333333,19.63333333,mod_diff,1,1,0,0,0,1,1,0,0,Not_Provided,Not_Provided,LOXO-101(NTRK1 LEVEL_3A),Entrectinib(NTRK1 LEVEL_3A),LEVEL_3A,2,Not_Provided,none,1,1,0,1,0,6.52173913,0.226692503,0.0,0.472861492
Metastasis,Cecum,Right,74,IV,0,MSS,0.89,mCRC Metastasis,0.0,1,0.0,10.0,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.A146T)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.166666667,0.201903058,0.666666667,0.723519536
Metastasis,Sigmoid Colon,Left,37,IV,0,MSS,0.24,mCRC Metastasis,0.0,0,0.0,1.333333333,mod_diff,0,0,1,0,0,0,0,1,0,"Cetuximab,Panitumumab(KRAS p.G12S)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.085031934,0.5,0.36392764
Primary,Sigmoid Colon,Left,64,IV,1,MSS,0.0,mCRC Primary,0.0,0,0.0,4.733333333,mod-poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,Not_Provided,LEVEL_2B,1,1,RAS,1,1,0,1,0,5.797101449,0.027739918,0.333333333,0.371561141
Primary,Sigmoid Colon,Left,36,IV,1,MSS,0.08,mCRC Primary,0.0,0,0.0,14.83333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.898550725,0.203058596,1.0,0.45160843
Metastasis,Hepatic Flexure,Right,72,IV,1,MSS,0.97,mCRC Metastasis,0.0,0,0.0,13.4,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,5.797101449,0.247688229,0.333333333,0.385491718
Primary,Sigmoid Colon,Left,58,IV,0,MSS,0.61,mCRC Primary,0.0,0,0.0,13.46666667,poorly-diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.239270446,0.142857143,0.471786398
Primary,Sigmoid Colon,Left,67,IV,1,MSS,0.3,mCRC Primary,0.0,0,0.0,42.13333333,mod-poorly-diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.666666667,0.149163711,0.333333333,0.414369277
Primary,Rectosigmoid,Left,42,III,1,MSS,0.58,mCRC Primary,0.0,1,30.46666667,3.1,mod-poorly-diff,0,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,alpelisib(PIK3CA p.E542K),LEVEL_3B,1,Not_Provided,PI3K,1,1,0,1,0,3.623188406,0.02701366,0.25,0.541784231
Primary,Cecum,Right,28,IV,0,MSI,35.78,mCRC Primary,0.0,0,0.0,159.3666667,Not_Provided,0,0,0,0,0,0,1,0,0,Not_Provided,Olaparib(BRCA2 p.T3033Lfs*29);Everolimus(TSC1 p.R420Qfs*22),Not_Provided,Not_Provided,LEVEL_2B,2,Not_Provided,PI3K,0,0,0,0,1,51.44927536,0.00196264,0.918918919,0.495049558
Primary,Ascending Colon,Right,50,IV,0,MSS,0.66,mCRC Primary,0.0,0,0.0,1.133333333,Not_Provided,0,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.177067617,0.111111111,0.34386507
Primary,Rectum,Left,41,III,1,MSI,23.53,mCRC Primary,0.0,0,23.8,-8.033333333,mod_diff,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,0,0,0,0,1,34.7826087,0.003743854,0.263157895,0.338144137
Metastasis,Splenic Flexure,Left,76,IV,1,MSI,37.98,mCRC Metastasis,0.0,1,0.0,6.0,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,2,PI3k_RAS,0,0,0,0,1,57.97101449,0.093749464,0.26984127,0.386025809
Metastasis,Sigmoid Colon,Left,63,IV,1,MSS,0.37,mCRC Metastasis,0.0,0,0.0,22.9,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(NRAS p.Q61L)",Not_Provided,Not_Provided,"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.Q61L)",LEVEL_3B,1,Not_Provided,RAS,1,1,0,1,0,5.0,0.274434494,0.0,0.41601467
Primary,Ascending Colon,Right,53,IV,1,MSS,0.35,mCRC Primary,0.0,0,0.0,40.6,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.E542K),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,5.072463768,0.351207051,0.166666667,0.446461255
Metastasis,Rectum,Left,61,III,1,MSS,3.35,mCRC Metastasis,0.0,1,2.733333333,19.46666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.5,0.281482754,0.5,0.435137312
Metastasis,Rectum,Left,39,III,1,MSS,1.3,mCRC Metastasis,0.0,1,20.06666667,73.56666667,mod-poorly-diff,1,0,1,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RTK_ONLY,1,1,0,1,0,9.166666667,0.351472735,0.222222222,0.426761773
Metastasis,Rectosigmoid,Left,44,IV,1,MSS,0.1,mCRC Metastasis,0.0,1,0.0,114.6333333,Not_Provided,1,0,1,0,0,0,0,0,0,Not_Provided,"ado-trastuzumab emtansine,Trastuzumab+Pertuzumab,Lapatinib,Trastuzumab(ERBB2 Amplification)",Not_Provided,"Lapatinib+Trastuzumab,Neratinib(ERBB2 Amplification)",LEVEL_2B,2,Not_Provided,RTK_ONLY,1,1,0,1,0,4.347826087,0.03905506,0.0,0.527537884
Primary,Ascending Colon,Right,72,II,1,MSS,0.33,Early Stage Primary,0.0,0,0.0,0.0,mod-poorly-diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3K,0,1,1,0,0,3.333333333,0.092581057,0.0,0.487175822
Metastasis,Cecum,Right,61,IV,0,MSS,3.02,mCRC Metastasis,0.0,1,0.0,59.86666667,mod_diff,0,0,0,0,0,0,1,1,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,7.246376812,0.66765266,0.25,0.431370849
Primary,Descending Colon,Left,65,IV,0,MSS,1.03,mCRC Primary,0.0,0,0.0,14.33333333,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)","Erlotinib,Gefitinib,Afatinib(EGFR p.L861Q)",Not_Provided,alpelisib(PIK3CA p.E542K),LEVEL_2B,2,Not_Provided,PI3k_RAS,1,1,0,1,0,12.5,0.010551969,0.153846154,0.485986714
Metastasis,Rectum,Left,43,III,1,MSS,0.0,mCRC Metastasis,0.0,0,68.2,12.63333333,Not_Provided,0,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,9.420289855,0.390948551,0.3,0.483269014
Primary,Hepatic Flexure,Right,66,IV,1,MSS,0.08,mCRC Primary,0.0,0,0.0,9.433333333,Not_Provided,1,1,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.5,0.013391406,0.5,0.37227049
Primary,Rectum,Left,67,IV,1,MSS,0.0,mCRC Primary,0.0,0,0.0,2.666666667,Not_Provided,1,0,1,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.347826087,0.087053644,0.5,0.474874615
Metastasis,Rectum,Left,57,IV,0,MSS,0.0,mCRC Metastasis,0.0,1,0.0,19.93333333,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,1.449275362,0.003670781,1.0,0.33916768
Metastasis,Cecum,Right,70,IV,1,MSS,0.45,mCRC Metastasis,0.0,0,0.0,6.533333333,Not_Provided,1,0,1,0,0,0,0,0,1,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.797101449,0.149501423,1.0,0.391765918
Metastasis,Sigmoid Colon,Left,51,IV,1,MSS,1.48,mCRC Metastasis,0.0,1,0.0,22.46666667,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.173913043,0.356764346,0.0,0.479657859
Primary,Sigmoid Colon,Left,45,IV,1,MSS,0.14,mCRC Primary,0.0,0,0.0,11.96666667,poorly-diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,6.52173913,0.01775397,0.285714286,0.433524171
Primary,Sigmoid Colon,Left,43,II,0,MSS,0.59,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,0,1,1,0,0,5.072463768,0.118146652,0.4,0.432900469
Metastasis,Rectum,Left,43,IV,0,MSS,1.7,mCRC Metastasis,0.0,1,0.0,67.63333333,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(NRAS p.G12D)",Not_Provided,Not_Provided,"Binimetinib+Ribociclib,Selumetinib+Radioiodine Uptake Therapy,Binimetinib(NRAS p.G12D)",LEVEL_3B,1,Not_Provided,RAS,1,1,0,1,0,3.623188406,0.156582609,0.666666667,0.292901703
Primary,Sigmoid Colon,Left,47,IV,1,MSS,0.0,mCRC Primary,0.0,0,0.0,2.533333333,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,AZD5363(AKT1 p.E17K),LEVEL_2B,2,1,PI3k_RAS,1,1,0,1,0,3.623188406,0.011440503,0.25,0.367214848
Metastasis,Sigmoid Colon,Left,51,II,0,MSS,0.0,mCRC Metastasis,0.0,1,23.03333333,11.26666667,mod_diff,0,0,0,0,0,0,1,1,1,"Cetuximab,Panitumumab(KRAS p.G12S)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,3.623188406,0.041950357,1.5,0.484147215
Primary,Sigmoid Colon,Left,48,IV,0,MSS,0.48,mCRC Primary,0.0,1,0.0,11.46666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.H1047R),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,4.166666667,0.036635378,0.25,0.442794212
Primary,Sigmoid Colon,Left,48,II,0,MSS,0.68,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,0,1,1,0,0,2.173913043,0.257796523,0.5,0.481110422
Primary,Rectum,Left,54,IV,0,MSS,0.0,mCRC Primary,0.0,1,0.0,1.9,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.623188406,0.098162186,0.0,0.42789967
Primary,Rectum,Left,57,II,1,MSS,0.0,Early Stage Primary,0.0,0,0.0,0.0,Not_Provided,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,0,1,1,0,0,2.898550725,0.179084161,0.0,0.444315522
Metastasis,Descending Colon,Left,59,III,1,MSS,1.03,mCRC Metastasis,0.0,1,31.8,66.66666667,Not_Provided,1,0,0,0,0,0,1,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,5.072463768,0.185745404,0.166666667,0.460476922
Primary,Sigmoid Colon,Left,65,IV,0,MSS,0.32,mCRC Primary,0.0,0,0.0,25.33333333,mod_diff,0,1,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.233755927,0.2,0.395815508
Primary,Ascending Colon,Right,78,III,1,MSS,2.58,mCRC Primary,0.0,0,7.3,31.3,mod_diff,0,1,0,0,0,0,1,0,0,Not_Provided,"Dabrafenib,Vemurafenib+Cobimetinib,Trametinib,Trametinib+Dabrafenib,Vemurafenib(BRAF p.V600E)",Not_Provided,Not_Provided,LEVEL_2B,1,1,PI3k_RAS,1,1,0,1,0,13.33333333,0.511059902,0.066666667,0.369332659
Metastasis,Rectosigmoid,Left,54,IV,0,MSS,0.17,mCRC Metastasis,0.0,0,0.0,3.733333333,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.173913043,0.075833539,0.5,0.392612854
Primary,Rectosigmoid,Left,46,III,1,MSS,0.0,mCRC Primary,0.0,0,16.56666667,11.96666667,mod_diff,0,0,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,4.347826087,0.070123957,0.0,0.332954229
Metastasis,Cecum,Right,51,IV,1,MSS,2.07,mCRC Metastasis,0.0,1,0.0,107.9666667,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,2.173913043,0.015406115,0.0,0.611583961
Primary,Cecum,Right,63,II,1,MSI,38.36,Early Stage Primary,0.0,0,0.0,0.0,poorly-diff,0,0,0,0,0,0,0,0,0,Not_Provided,Olaparib(BRCA2 p.V1862*);Everolimus(TSC2 p.L448P),Not_Provided,Not_Provided,LEVEL_2B,2,Not_Provided,PI3K,0,0,0,0,1,54.34782609,0.011217126,0.461538462,0.427588869
Metastasis,Sigmoid Colon,Left,67,IV,1,MSS,1.28,mCRC Metastasis,0.0,0,0.0,3.766666667,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.347826087,0.323821942,0.2,0.39605757
Metastasis,Rectum,Left,65,III,1,MSS,0.09,mCRC Metastasis,0.0,1,22.43333333,13.43333333,Not_Provided,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.093287209,0.166666667,0.394884142
Metastasis,Sigmoid Colon,Left,76,IV,1,MSS,3.28,mCRC Metastasis,0.0,0,0.0,54.96666667,mod diff,1,1,1,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12C)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.E545K),LEVEL_3B,1,Not_Provided,PI3k_RAS,0,0,0,0,0,7.246376812,0.27461407,0.111111111,0.447627115
Primary,Rectum,Left,77,III,1,MSS,0.31,Early Stage Primary,0.0,0,0.0,0.0,Not_Provided,0,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.Q546K),LEVEL_3B,1,Not_Provided,PI3k_RAS,0,1,1,0,0,4.347826087,0.060538247,0.2,0.552426786
Primary,Rectum,Left,72,IV,1,MSS,0.47,mCRC Primary,0.0,0,0.0,41.8,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Olaparib(BRCA2 p.Q1551*),Not_Provided,Not_Provided,LEVEL_2B,1,Not_Provided,none,1,1,0,1,0,8.333333333,0.271372193,0.428571429,0.290356448
Primary,Rectum,Left,64,IV,1,MSS,0.76,mCRC Primary,0.0,0,0.0,34.86666667,mod-poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,3.333333333,0.527831658,0.333333333,0.710606738
Primary,Sigmoid Colon,Left,62,II,0,MSS,0.0,mCRC Primary,0.0,1,4.5,7.133333333,mod_diff,0,0,0,0,0,0,0,0,1,Not_Provided,Not_Provided,Not_Provided,alpelisib(PIK3CA p.M1043V),LEVEL_3B,1,Not_Provided,PI3K,1,1,0,1,0,7.5,0.044448489,0.125,0.376461886
Primary,Sigmoid Colon,Left,57,IV,1,MSS,0.5,mCRC Primary,0.0,1,0.0,5.666666667,mod_diff,1,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.166666667,0.266193543,0.666666667,0.437825804
Metastasis,Rectosigmoid,Left,45,III,1,MSS,1.43,mCRC Metastasis,0.0,1,35.7,2.4,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,2.898550725,0.23984966,0.333333333,0.459964252
Primary,Sigmoid Colon,Left,25,IV,0,MSS,0.0,mCRC Primary,0.0,0,0.0,6.533333333,mod_diff,1,1,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,3.623188406,0.016866222,0.25,0.317745685
Primary,Sigmoid Colon,Left,70,IV,0,MSS,0.88,mCRC Primary,0.0,1,0.0,107.4,mod_diff,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,alpelisib(PIK3CA p.H1047R),LEVEL_3B,1,Not_Provided,PI3k_RAS,1,1,0,1,0,7.246376812,0.308917267,0.0,0.592003526
Primary,Sigmoid Colon,Left,45,II,0,MSS,0.16,mCRC Primary,0.0,0,13.26666667,5.933333333,poorly-diff,0,1,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,1,1,0,1,0,4.166666667,0.218868325,0.0,0.420065645
Primary,Ascending Colon,Right,74,IV,1,MSS,0.67,mCRC Primary,0.0,0,0.0,4.366666667,mod_diff,1,0,0,0,0,0,1,0,1,"Cetuximab,Panitumumab(KRAS p.G12D)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,PI3k_RAS,1,1,0,1,0,4.347826087,0.240878242,0.0,0.335093332
Metastasis,Ascending Colon,Right,65,IV,1,MSI,42.22,mCRC Metastasis,0.0,0,0.0,2.1,Not_Provided,0,0,0,0,0,0,1,0,0,"Cetuximab,Panitumumab(KRAS p.G13D)",Not_Provided,Not_Provided,Neratinib(ERBB2 p.V842I),LEVEL_3B,1,Not_Provided,PI3k_RAS,0,0,0,0,1,65.94202899,0.177601564,0.467741935,0.44913069
Primary,Rectosigmoid,Left,75,I,1,MSS,0.16,Early Stage Primary,0.0,0,0.0,0.0,mod_diff,0,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,none,0,1,1,0,0,6.52173913,0.302669433,0.5,0.362108136
Metastasis,Rectum,Left,50,II,1,MSS,0.42,mCRC Metastasis,0.0,1,43.2,41.2,mod_diff,1,0,0,0,0,0,0,0,0,Not_Provided,Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RTK_ONLY,1,1,0,1,0,2.173913043,0.323541193,2.0,0.60217353
Metastasis,Sigmoid Colon,Left,49,IV,0,MSS,0.16,mCRC Metastasis,0.0,0,0.0,1.666666667,Not_Provided,1,0,0,0,0,0,0,0,0,"Cetuximab,Panitumumab(KRAS p.G12V)",Not_Provided,Not_Provided,Not_Provided,Not_Provided,0,Not_Provided,RAS,1,1,0,1,0,5.072463768,0.19126078,0.0,0.427803082
Metastasis,Sigmoid Colon,Left,67,I,1,MSS,1.88,mCRC Metastasis,0.0,0,88.0,3.733333333,mod-poorly-diff,1,0,0,0,0,0,0,0,0,Not_Provided,Olaparib(BRCA2 p.T1359Yfs*2),Not_Provided,Not_Provided,LEVEL_2B,1,Not_Provided,none,1,1,0,1,0,7.246376812,0.420296616,0.25,0.480352524
